Related Experiment Video
Updated: Jul 13, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Hemoptysis in Cancer Patients
Emad D Singer1,2, Saadia A Faiz3, Aiham Qdaisat1
1Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
This review examines hemoptysis (coughing up blood) in cancer patients, suggesting a new approach beyond blood volume. It emphasizes risk factors and mortality to improve patient care and treatment planning.
Area of Science:
- Oncology
- Pulmonology
- Critical Care Medicine
Background:
- Hemoptysis in cancer patients stems from diverse causes like infections, tumors, and vascular issues.
- Current volume-based classifications of hemoptysis may not fully capture clinical severity.
- A comprehensive evaluation is needed for effective cancer patient management.
Purpose of the Study:
- To explore a comprehensive approach to evaluating hemoptysis in cancer patients.
- To analyze risk factors, epidemiology, and clinical consequences of hemoptysis in this population.
- To highlight the necessity of a specific mortality prediction score for cancer patients experiencing hemoptysis.
Main Methods:
- Literature review focusing on hemoptysis in cancer patients.
- Analysis of risk factors, mortality rates, and clinical impact.
- Exploration of current and potential management strategies.
Main Results:
- Identifies key risk factors contributing to hemoptysis in cancer patients.
- Provides insights into mortality rates associated with hemoptysis in this demographic.
- Underscores limitations of volume-based hemoptysis definitions.
Conclusions:
- A comprehensive evaluation, including risk stratification, is crucial for managing hemoptysis in cancer patients.
- Developing a cancer-specific mortality prediction score is essential.
- Optimizing bleeding control, interventions, and supportive care improves patient outcomes and quality of life.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumothorax-II
Clinical Manifestations:
Venous Thrombosis IV: Nursing Management

